1 |
100 mg elx /50 mg tez /75 mg iva fdc |
- |
- |
- |
- |
299 1件: 299 💬 |
2 |
100 mg elx/50 mg tez /75 mg iva fdc |
- |
- |
- |
- |
299 1件: 299 💬 |
3 |
100 mg elx/50 mg tez/75 mg iva fixed dose combination |
- |
- |
- |
- |
299 1件: 299 💬 |
4 |
100 mg vx-445/50 mg tez /75 mg iva fdc |
- |
- |
- |
- |
299 1件: 299 💬 |
5 |
100-mg elx (vx-445) / 50-mg tez / 75-mg iva fdc |
- |
- |
- |
- |
299 1件: 299 💬 |
6 |
100-mg elx (vx-455) / 50-mg tez / 75-mg iva fdc |
- |
- |
- |
- |
299 1件: 299 💬 |
7 |
100-mg elx / 50-mg tez / 75 -mg iva fdc |
- |
- |
- |
- |
299 1件: 299 💬 |
8 |
100-mg vx-445 / 50-mg tez / 75-mg iva fdc |
- |
- |
- |
- |
299 1件: 299 💬 |
9 |
100-mg vx-445 /50-mg tez/75-mg |
- |
- |
- |
- |
299 1件: 299 💬 |
10 |
100-mg vx-445/50-mg tez/75-mg iva fdc |
- |
- |
- |
- |
299 1件: 299 💬 |
11 |
100mg vx-445/50mg tez /75mg iva fdc |
- |
- |
- |
- |
299 1件: 299 💬 |
12 |
56/104/75-c |
- |
- |
- |
- |
050 1件: 50 💬 |
13 |
75 |
- |
- |
- |
- |
006 1件: 6 💬 |
14 |
75 mg ontamalimab |
Ontamalimab |
- |
- |
- |
096 2件: 96, 97 💬 |
15 |
750 mg metformin and 7.5 g l-citrulline daily p.o. |
Citrulline |
3件: D00944 D00944, D04966 D04966, D07706 D07706 💬 |
PRKAA1 2件: PRKAA1, PRKAA2 💬 |
AMPK signaling pathway 19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
113 1件: 113 💬 |
16 |
750mg mesalazine pellets |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
17 |
75mg cxa-10 |
CXA-10 |
- |
- |
- |
086 1件: 86 💬 |
18 |
75mg shp647 (pf-00547659) |
- |
- |
- |
- |
097 1件: 97 💬 |
19 |
Ain457, 75 mg |
- |
- |
- |
- |
271 1件: 271 💬 |
20 |
Atacicept 75 mg |
Atacicept |
1件: D09704 D09704 💬 |
TNFSF13 2件: TNFSF13, TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
013 3件: 13, 49, 66 💬 |
21 |
Atacicept 75 milligram (mg) |
Atacicept |
1件: D09704 D09704 💬 |
TNFSF13 2件: TNFSF13, TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
049 1件: 49 💬 |
22 |
Azli 75 mg three times a day (tid) |
- |
- |
- |
- |
299 1件: 299 💬 |
23 |
Azli 75 mg three times daily (tid) |
- |
- |
- |
- |
299 1件: 299 💬 |
24 |
Azli 75 mg two times a day (bid)/ three times a day (tid) |
- |
- |
- |
- |
299 1件: 299 💬 |
25 |
Azli 75 mg two times a day (bid)/three times a day (tid) |
- |
- |
- |
- |
299 1件: 299 💬 |
26 |
Bms-986004 75 mg iv |
- |
- |
- |
- |
063 1件: 63 💬 |
27 |
Bupivacaine |
Bupivacaine |
2件: D01450 D01450, D07552 D07552 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
046 8件: 46, 51, 53, 70, 96, 168, 226, 298 💬 |
28 |
Bupivacaine hydrochloride |
Bupivacaine |
2件: D01450 D01450, D07552 D07552 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
046 2件: 46, 53 💬 |
29 |
Bupivacaine hydrochloride 0.5% (marcaine, pfizer) |
Bupivacaine |
2件: D01450 D01450, D07552 D07552 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
046 1件: 46 💬 |
30 |
Bupivacaine injection 0.5% |
Bupivacaine |
2件: D01450 D01450, D07552 D07552 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
168 1件: 168 💬 |
31 |
Bupivacaine/epinephrine/dexamethasone |
Bupivacaine |
14件: D00095 D00095, D00292 D00292, D00975 D00975, D00996 D00996, D01450 D01450, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02149 D02149, D02174 D02174, D02591 D02591, D02592 D02592, D07552 D07552 💬 |
ADRA1A 15件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, NR3C1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
AMPK signaling pathway 15件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
096 1件: 96 💬 |
32 |
Cayston 75 mg pulver und lösungsmittel zur herstellung einer lösung für einen vernebler |
- |
- |
- |
- |
299 1件: 299 💬 |
33 |
Cayston aztreonam 75 mg powder and solvent for nebuliser solution |
Aztreonam |
2件: D00240 D00240, D06558 D06558 💬 |
- |
- |
299 1件: 299 💬 |
34 |
Certican 0,75mg |
- |
- |
- |
- |
228 1件: 228 💬 |
35 |
Certican 0,75mg tabletten |
- |
- |
- |
- |
228 1件: 228 💬 |
36 |
Cohort 2 0.75g |
- |
- |
- |
- |
240 1件: 240 💬 |
37 |
Colistimethate 75 mg inhaled two times daily |
Colistimethate |
1件: D02049 D02049 💬 |
- |
- |
299 1件: 299 💬 |
38 |
Cvl-751 |
- |
- |
- |
- |
006 1件: 6 💬 |
39 |
Depot leuprolide acetate 3.75 mg |
Acetate |
2件: D00989 D00989, D08113 D08113 💬 |
GNRHR 1件: GNRHR 💬 |
GnRH signaling pathway 2件: GnRH signaling pathway, Neuroactive ligand-receptor interaction |
051 1件: 51 💬 |
40 |
Efexor xl 75 mg |
- |
- |
- |
- |
046 1件: 46 💬 |
41 |
Efexor xl 75 mg (venlafaxine) |
Venlafaxine |
2件: D00821 D00821, D08670 D08670 💬 |
SLC6A2 2件: SLC6A2, SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
046 1件: 46 💬 |
42 |
Ercp with bupivacaine infusion |
Bupivacaine |
2件: D01450 D01450, D07552 D07552 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
298 1件: 298 💬 |
43 |
Incobotulinumtoxina (75 units) |
Botulinum toxin type A |
1件: D00783 D00783 💬 |
SNAP25 1件: SNAP25 💬 |
Insulin secretion 2件: Insulin secretion, Synaptic vesicle cycle |
006 1件: 6 💬 |
44 |
Inhaled nitric oxide 75 mcg/kg ibw/hr |
Nitric Oxide |
1件: D00074 D00074 💬 |
- |
- |
085 2件: 85, 86 💬 |
45 |
Ivacaftor 25 mg/75 mg |
Ivacaftor |
1件: D09916 D09916 💬 |
CFTR 1件: CFTR 💬 |
ABC transporters 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway |
299 1件: 299 💬 |
46 |
Ivacaftor 75 mg |
Ivacaftor |
1件: D09916 D09916 💬 |
CFTR 1件: CFTR 💬 |
ABC transporters 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway |
299 1件: 299 💬 |
47 |
Ivacaftor 75 mg/150 mg |
Ivacaftor |
1件: D09916 D09916 💬 |
CFTR 1件: CFTR 💬 |
ABC transporters 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway |
299 1件: 299 💬 |
48 |
Jaktinib dihydrochloride monohydrate 50mg bid and mimic tablets of jakitinib hydrochloride 75mg bid and acetylcysteine effervescent tablets |
Acetylcysteine |
1件: D00221 D00221 💬 |
- |
- |
085 1件: 85 💬 |
49 |
Jaktinib dihydrochloride monohydrate 75mg bid and mimic tablets of jakitinib hydrochloride 50mg bid and acetylcysteine effervescent tablets |
Acetylcysteine |
1件: D00221 D00221 💬 |
- |
- |
085 1件: 85 💬 |
50 |
Jnj-54781532 75 mg once daily |
- |
- |
- |
- |
097 1件: 97 💬 |
51 |
Jnj-54781532 75 mg twice daily |
- |
- |
- |
- |
097 1件: 97 💬 |
52 |
Lap tap bupivacaine/epinephrine |
Bupivacaine |
5件: D00095 D00095, D00996 D00996, D01450 D01450, D02149 D02149, D07552 D07552 💬 |
ADRA1A 14件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
AMPK signaling pathway 15件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
096 1件: 96 💬 |
53 |
Leuprorelin acetate 3.75mg injection |
Acetate |
2件: D00989 D00989, D08113 D08113 💬 |
GNRHR 1件: GNRHR 💬 |
GnRH signaling pathway 2件: GnRH signaling pathway, Neuroactive ligand-receptor interaction |
076 1件: 76 💬 |
54 |
Levodopa 75 mg a cap |
Levodopa |
1件: D00059 D00059 💬 |
DRD1 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
55 |
Liposomal bupivacaine |
Bupivacaine |
2件: D01450 D01450, D07552 D07552 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
051 3件: 51, 70, 96 💬 |
56 |
Liq861 75 µg |
- |
- |
- |
- |
086 1件: 86 💬 |
57 |
Luphere depot 3.75mg(leuprolide acetate 3.75mg) |
Acetate |
2件: D00989 D00989, D08113 D08113 💬 |
GNRHR 1件: GNRHR 💬 |
GnRH signaling pathway 2件: GnRH signaling pathway, Neuroactive ligand-receptor interaction |
076 1件: 76 💬 |
58 |
M2951 75 mg qd |
- |
- |
- |
- |
046 1件: 46 💬 |
59 |
Macitentan 75 mg |
Macitentan |
1件: D10135 D10135 💬 |
EDNRA 2件: EDNRA, EDNRB 💬 |
Calcium signaling pathway 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 1件: 86 💬 |
60 |
Metohexal® succ ® 23,75 mg retardtabletten |
- |
- |
- |
- |
113 1件: 113 💬 |
61 |
Oral glucose tolerance test (75g 2-hour) |
Dextrose, unspecified form |
- |
- |
- |
299 1件: 299 💬 |
62 |
Other: glucose solution at a dose of 1.75 g/kg (up to a maximum of 75 g) for the ogtt and glucose solution at a dose of 0.5 g/kg (up to a maximum of 35 g) was injected in 2.5-3 min for the igtt |
Dextrose, unspecified form |
- |
- |
- |
299 1件: 299 💬 |
63 |
Over-encapsulated 75 mg irbesartan tablets |
Irbesartan |
1件: D00523 D00523 💬 |
AGTR1 1件: AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
222 1件: 222 💬 |
64 |
P2b001 once daily (pramipexole 0.3 mg / rasagiline 0.75 mg), |
Pramipexole |
5件: D00559 D00559, D02562 D02562, D05575 D05575, D08469 D08469, D10829 D10829 💬 |
DRD2 4件: DRD2, DRD3, DRD4, MAOB 💬 |
Alcoholism 18件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
65 |
P2b001 once daily (pramipexole 0.6 mg / rasagiline 0.75 mg), |
Pramipexole |
5件: D00559 D00559, D02562 D02562, D05575 D05575, D08469 D08469, D10829 D10829 💬 |
DRD2 4件: DRD2, DRD3, DRD4, MAOB 💬 |
Alcoholism 18件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
66 |
P38 inhibitor (4) 75mg |
- |
- |
- |
- |
046 1件: 46 💬 |
67 |
Pregabalin 75mg |
Pregabalin |
1件: D02716 D02716 💬 |
CACNA2D1 4件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 💬 |
Adrenergic signaling in cardiomyocytes 7件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway |
070 1件: 70 💬 |
68 |
Ranexa*60cpr 750mg r.p. |
- |
- |
- |
- |
058 1件: 58 💬 |
69 |
Ranolazine 750 mg pr tablets |
Ranolazine |
2件: D05700 D05700, D05701 D05701 💬 |
- |
- |
058 1件: 58 💬 |
70 |
Ranolazine pr (prolonged-release) 500 mg 1 tablet bis in die and 750 mg 1 tablet bis in die |
Ranolazine |
2件: D05700 D05700, D05701 D05701 💬 |
- |
- |
058 1件: 58 💬 |
71 |
Revolade 75 mg |
- |
- |
- |
- |
060 1件: 60 💬 |
72 |
Rhudex 25 mg (31.75 mg rhudex choline salt) granules |
Choline |
1件: D07690 D07690 💬 |
- |
- |
093 1件: 93 💬 |
73 |
Ro 487-7533 |
- |
- |
- |
- |
046 1件: 46 💬 |
74 |
Ro 487-7533/f01 |
- |
- |
- |
- |
046 2件: 46, 271 💬 |
75 |
Ro 487-7533/f10 |
- |
- |
- |
- |
046 1件: 46 💬 |
76 |
Ro 487-7533/f10-02 |
- |
- |
- |
- |
046 1件: 46 💬 |
77 |
Ro 487-7533/f10-04 |
- |
- |
- |
- |
041 4件: 41, 46, 51, 107 💬 |
78 |
Ro 491-7523/f18 |
- |
- |
- |
- |
206 1件: 206 💬 |
79 |
Ro 491-7523/f19 |
- |
- |
- |
- |
206 1件: 206 💬 |
80 |
Ro487-7533 |
- |
- |
- |
- |
046 1件: 46 💬 |
81 |
Ro487-7533/f01-f05 |
- |
- |
- |
- |
046 1件: 46 💬 |
82 |
Ro487-7533/f10-04 |
- |
- |
- |
- |
046 2件: 46, 51 💬 |
83 |
Secukinumab (75 mg) |
Secukinumab |
1件: D09967 D09967 💬 |
IL17A 1件: IL17A 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation |
271 1件: 271 💬 |
84 |
Secukinumab 75 mg/0.5 ml solution for injection |
Secukinumab |
1件: D09967 D09967 💬 |
IL17A 1件: IL17A 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation |
271 1件: 271 💬 |
85 |
Suspension containing 7500 embryonated viable trichuris suis ova/15ml |
- |
- |
- |
- |
097 1件: 97 💬 |
86 |
Suspension containing 7500 embryonated, viable trichuris suis ova (tso)/15ml |
- |
- |
- |
- |
096 1件: 96 💬 |
87 |
Suspension of 7500 embryonated, viable tso/15ml |
- |
- |
- |
- |
096 1件: 96 💬 |
88 |
Tak-755 orbax930 or shp655 |
- |
- |
- |
- |
064 1件: 64 💬 |
89 |
Trulicity 0,75 mg injekcný roztok naplnený v injekcnom pere |
- |
- |
- |
- |
013 1件: 13 💬 |
90 |
Trulicity 0,75 mg injekcný roztok naplnený v injekcnom pere. |
- |
- |
- |
- |
013 1件: 13 💬 |
91 |
Tso 7500 |
- |
- |
- |
- |
096 1件: 96 💬 |
92 |
Us tap bupivacaine/epinephrine |
Bupivacaine |
5件: D00095 D00095, D00996 D00996, D01450 D01450, D02149 D02149, D07552 D07552 💬 |
ADRA1A 14件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
AMPK signaling pathway 15件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
096 1件: 96 💬 |
93 |
Vamorolone 0.75 mg/day/day |
Vamorolone |
1件: D11000 D11000 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
113 1件: 113 💬 |
94 |
Vamorolone 0.75 mg/kg/day |
Vamorolone |
1件: D11000 D11000 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
113 1件: 113 💬 |
95 |
Veltuzumab solution 75mg/ml |
Veltuzumab |
1件: D09031 D09031 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
046 1件: 46 💬 |
96 |
Vx-661/ivacaftor 50 mg/ 75 mg |
Ivacaftor |
1件: D09916 D09916 💬 |
CFTR 1件: CFTR 💬 |
ABC transporters 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway |
299 1件: 299 💬 |
97 |
Xyosted 75 milligram (mg) in 0.5 ml auto-injector |
- |
- |
- |
- |
013 1件: 13 💬 |